Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Expijoy Nutra is a herbo-nutraceutical dietary supplement developed by Charak Pharma to support female reproductive health, hormonal balance, and fertility. Formulated as an oral tablet, it contains a synergistic combination of dehydroepiandrosterone (DHEA), phytoextracts such as Shatavari (Asparagus racemosus) and Yastimadhu (Glycyrrhiza glabra), amino acids (including L-carnitine and N-acetylcysteine), folic acid, multivitamins, and essential minerals. Expijoy Nutra is designed to regulate ovulation, improve oocyte quality and ovarian reserve, maintain a healthy menstrual cycle, and support endometrial thickness to optimize female fertility and pregnancy outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Expijoy Nutra.